Vimarsana
Biggest News Aggregation in the World

Page 25 - Oncology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Program Today - Breaking & Trending Today

Kristen Bell Selects The Winners Of The Prostate Cancer Foundation's Fourth Annual TRUE Love Contest - Vimarsana News

Kristen Bell Selects The Winners Of The Prostate Cancer Foundation's Fourth Annual TRUE Love Contest

Kristen Bell Selects The Winners Of The Prostate Cancer Foundation's Fourth Annual TRUE Love Contest TRUE Love contest recognizes extraordinary cancer caregivers News provided by Share this article Share this article LOS ANGELES, March 11, 2021 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and actress Kristen Bell announced today the winners of the fourth annual TRUE Love Contest that honors caregivers and supporters of prostate cancer patients. Bell chose two heartfelt stories of compassionate care from among many inspirational submissions – one from John Strizver of Ramona, Califo...

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients - Vimarsana News

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients Chimeric antigen receptor T-cell therapy, or CAR T, has been a breakthrough in the treatment of blood cancers such as acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Clinical studies have shown overall response rates of more than 80% with an ongoing response of nearly 40% more than two years after therapy. However, the cellular immunotherapy doesn't work for every patient. Moffitt Cancer Center, one of the leading centers for cellular immunotherapy, is researching why some patients have a b...

Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering - Vimarsana News

Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering

Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering Nanobiotix will use a portion of the proceeds from the its IPO to launch its global phase III registration study in head and neck cancer in the United States in 2021 Following previously reported preliminary data regarding the ability of NBTXR3 to help transform anti-PD-1 non-responders into responders, the Company will provide the next update on its immuno-oncology phase I basket study evaluating NBTXR3 in combination with anti-PD-1 checkpoint inhibitors in the second quarter of 2021 The ...